The Stem Cell Podcast

Ep. 216: “Liver Tissue Development & Engineering” Featuring Dr. David Hay

Apr 19, 2022

01:06:38

Creator website

Highlights

AI Chapters

Episode notes

How to Induce Chemical Reprogramming in Human Cells

03:33

I Think the Invitro Side Is Really Exciting

04:10

Stem Cell Therapy

03:14

Introduction

2min

Using Chemical Stimulation in Mouse Somatic Cells to Induce Pluri Potent Stem Cells

3min

Is There a Future for Chemical Reprogramming to Generate Pluripotent Cells?

2min

How to Induce Chemical Reprogramming in Human Cells

4min

Sematic Mutation Rates Scale With LifeSpan

3min

The LifeSpan Question Isn't Solved, but Is It?

4min

Is Hemana Poetic Stem Cell Transplantable?

3min

Hemata Poetic Stem Cell Self Signature

3min

Pluri-Po or Matapotic a Precursor?

1min

10.

Is This the Culmination of Our Ability to Examine Hedorigineity Within Populations?

3min

11.

Using Primordial Germ Cell Like Cells From Rat Pluripotent Stem Cells

2min

12.

Are Human Pluripotent Stem Cells Safe?

2min

13.

The Application of Human Stem Cells to Preservation

3min

14.

Hepaticult Organoide Kit - Slash Hepatic Disease

2min

15.

Hippatacite Production From Pluripotent Stem Cells

2min

16.

Using Cell Base Therapies in the Clinical Trials

3min

17.

Transplantation

5min

18.

I Think the Invitro Side Is Really Exciting

4min

19.

The Importance of Machine Learning in a Cell Production System

3min

20.

Stem Cell Therapy

3min

21.

Biotex Start Up Companies - Are You Bringing It to Clinical Trials?

2min

22.

Regenerative Medicine - It's All About Team Building

4min

23.

I Can't Start to Day Without Tea and Coffee

3min

Dr. David Hay is the Chair of Tissue Engineering at the University of Edinburgh, where his group is defining novel ways to produce liver tissue from PSCs. They use in vitro derived tissue to better model human liver physiology and to develop supportive cell based therapies for disease. Dr. Hay also founded Stimuliver, a company that is developing a disruptive liver implant to treat critically failing liver function in humans. He talks about hepatocyte differentiation, liver disease modeling, and automating the production of cell therapies.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.